FTXH icon

First Trust Nasdaq Pharmaceuticals ETF
FTXH

Overview Fund Activity

25 hedge funds and large institutions have $12.9M invested in First Trust Nasdaq Pharmaceuticals ETF in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 8 closing their positions.

Holders
25
Holders Change
-6
Holders Change %
-19.35%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
10
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
OMC
1
Old Mission Capital
Illinois
$568K
2
Citadel Advisors
2
Citadel Advisors
Florida
$602K
3
Goldman Sachs
3
Goldman Sachs
New York
$216K
4
PPWM
4
Paragon Private Wealth Management
Kentucky
$686K
5
UBS Group
5
UBS Group
Switzerland
$112K

Top Sellers

1
SPIA
1
Steward Partners Investment Advisory
New York
$395K
2
Truist Financial
2
Truist Financial
North Carolina
$0
3
NP
3
Nilsine Partners
Colorado
$0
4
GSIAS
4
Garden State Investment Advisory Services
New Jersey
$0
5
CAN
5
Cetera Advisor Networks
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Truist Financial
26
Truist Financial
North Carolina
– -$1.2M -45,988 Closed
NP
27
Nilsine Partners
Colorado
– -$1.13M -43,186 Closed
GSIAS
28
Garden State Investment Advisory Services
New Jersey
– -$565K -21,645 Closed
CAN
29
Cetera Advisor Networks
California
– -$352K -13,491 Closed
RJA
30
Raymond James & Associates
Florida
– -$296K -11,336 Closed
Janney Montgomery Scott
31
Janney Montgomery Scott
Pennsylvania
– -$276K -10,574 Closed
FIA
32
Foundations Investment Advisors
Arizona
– -$200K -7,666 Closed
CFGS
33
Concourse Financial Group Securities
Alabama
– -$67.2K -2,576 Closed
1
2